ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
51.01
+0.53 (1.05%)
At close: Aug 1, 2025, 4:00 PM
51.01
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:15 PM EDT
BIB Holdings Information
BIB is an equity ETF with a total of 264 individual holdings. The top holdings are NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG stock at 31.10%, NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA at 27.34%, NASDAQ BIO INDEX SWAP BNP PARIBAS at 26.03%, NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE at 16.82%, and NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL at 16.78%.
Total Holdings
264
Top 10 Percentage
151.46%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
51.72M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 31.10% |
2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 27.34% |
3 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 26.03% |
4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.82% |
5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 16.78% |
6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 13.89% |
7 | VRTX | Vertex Pharmaceuticals Incorporated | 5.16% |
8 | AMGN | Amgen Inc. | 5.11% |
9 | GILD | Gilead Sciences, Inc. | 5.09% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 4.14% |
11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.22% |
12 | AZN | AstraZeneca PLC | 3.12% |
13 | ARGX | argenx SE | 1.53% |
14 | SMMT | Summit Therapeutics Inc. | 1.41% |
15 | INSM | Insmed Incorporated | 1.41% |
16 | BIIB | Biogen Inc. | 1.35% |
17 | ILMN | Illumina, Inc. | 1.17% |
18 | RPRX | Royalty Pharma plc | 1.12% |
19 | INCY | Incyte Corporation | 1.05% |
20 | SNY | Sanofi | 0.93% |
21 | NBIX | Neurocrine Biosciences, Inc. | 0.92% |
22 | ONC | BeOne Medicines Ltd. | 0.90% |
23 | UTHR | United Therapeutics Corporation | 0.89% |
24 | MEDP | Medpace Holdings, Inc. | 0.89% |
25 | MRNA | Moderna, Inc. | 0.83% |
As of Jul 31, 2025